Ali Mtoro

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

Michael White, Robert Verity, Jamie T. Griffin et al. · The Lancet Infectious Diseases · 2015 · 344 citations · Full text

Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian Adults

Said Jongo, Seif Shekalaghe, L. W. Preston Church et al. · American Journal of Tropical Medicine and Hygiene · 2018 · 160 citations · Full text

Safety and Differential Antibody and T-Cell Responses to the Plasmodium falciparum Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants

Said Jongo, L. W. Preston Church, Ali Mtoro et al. · American Journal of Tropical Medicine and Hygiene · 2019 · 79 citations · Full text

Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults

Said Jongo, L. W. Preston Church, Ali Mtoro et al. · Clinical Infectious Diseases · 2019 · 70 citations · Full text

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

Yolanda Guerra Mendoza, Elodie Garric, Amanda Leach et al. · Human Vaccines & Immunotherapeutics · 2019 · 65 citations · Full text